What is Voicebrook?
Voicebrook operates at the intersection of healthcare technology and clinical diagnostics, providing specialized software solutions such as VoiceOver PRO and SynoptIQ eCP. The company addresses critical pain points in anatomic pathology by automating reporting workflows and ensuring strict adherence to CAP eCP standards. By reducing manual entry errors and accelerating turnaround times, Voicebrook empowers pathology labs to enhance diagnostic accuracy. Their platform is engineered for seamless integration with existing laboratory information systems, positioning the company as a vital partner for healthcare institutions aiming to modernize their diagnostic capabilities and prioritize patient-centric outcomes.
How much funding has Voicebrook raised?
Voicebrook has raised a total of $2.2M across 2 funding rounds:
Debt
$1M
Debt
$1.2M
Debt (2020): $1M with participation from PPP
Debt (2021): $1.2M led by PPP
Key Investors in Voicebrook
PPP
Public-Private Partnership
What's next for Voicebrook?
With the recent influx of capital, Voicebrook is well-positioned to accelerate its product roadmap and expand its footprint within the pathology informatics market. The company is expected to focus on deepening the integration capabilities of its SynoptIQ eCP platform, potentially exploring advanced analytics or AI-driven diagnostic support tools. As the healthcare industry continues to prioritize digital transformation, Voicebrook's focus on reducing administrative burden and improving clinical precision will likely drive further adoption among large-scale pathology networks. Future strategic initiatives will likely center on scaling customer success operations and maintaining its competitive edge in the specialized niche of anatomic pathology reporting.
See full Voicebrook company page
